thiophenes has been researched along with Hepatic Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheen, AJ | 1 |
| Gulseth, MP; Michaud, J; Nutescu, EA | 1 |
| Alatrach, A; Becka, M; Halabi, A; Hinrichsen, H; Kubitza, D; Mueck, W; Roth, A | 1 |
2 review(s) available for thiophenes and Hepatic Insufficiency
| Article | Year |
|---|---|
Evaluating SGLT2 inhibitors for type 2 diabetes: pharmacokinetic and toxicological considerations.
Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Interactions; Glucosides; Hepatic Insufficiency; Humans; Hypoglycemic Agents; Membrane Transport Modulators; Renal Insufficiency; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
Rivaroxaban: an oral direct inhibitor of factor Xa.
Topics: Aging; Antithrombin III; Clinical Trials as Topic; Drug Interactions; Fibrinolytic Agents; Hepatic Insufficiency; Humans; Morpholines; Obesity; Prothrombin Time; Renal Insufficiency; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2008 |
1 trial(s) available for thiophenes and Hepatic Insufficiency
| Article | Year |
|---|---|
Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Area Under Curve; Case-Control Studies; Factor Xa Inhibitors; Female; Hepatic Insufficiency; Humans; Least-Squares Analysis; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Polyamines; Prothrombin Time; Rivaroxaban; Sevelamer; Thiophenes | 2013 |